The eighth pan-European Science Conference on QbD and PAT Sciences brings together pharmaceutical scientists and engineers from industry, academia and regulatory agencies to discuss recent developments and future trends in the field of pharmaceutical product and process development. The 8th EuPAT conference will focus on PAT integration into pharmaceutical manufacturing, the biopharmaceutics risk assessment roadmap (BioRAM) for the integration of preclinical, clinical and pharmaceutical development including QbD for better products and QbD considerations for emerging therapies (biosimilars and nanomedicines). Technical, practical and regulatory challenges in each of these focus areas will be explored and debated in detail. The conference builds on the success of the EuPAT series established in 2006 and will be organised by EUFEPS and its QbD and PAT Sciences Network, cosponsored by the University College Cork (UCC), the Irish based Synthesis and Solid State Pharmaceutical Centre (SSPC) and Pharmaceutical Manufacturing Technology Centre (PMTC). The main meeting will be held on October 3rd and 4th, 2016, in UCC, Cork, Ireland. It is organised back-to-back with a training day centred on “Considerations for implementing a PAT technology into a new or existing pharma process”, which is scheduled to commence on October 2nd, 2016, at the School of Pharmacy, UCC, Ireland. The attendees of EuPAT8 are welcome to register for the pre-conference day and vice versa. See website for programme, call for abstracts, fees, registration and accommodation information.
See website for preliminary programme, abstract submission, pre-conference workshop, exhibition and sponsorship options, early-bird and later fees, registration
and accommodation information.
Session Topics at EuPAT 8
• PAT implementation in manufacturing II (biologics)
• Biopharmaceutics risk assessment roadmap (BioRAM)
• Biosimilars and Nanomedicines